Dosage Forms

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

BMS Receives FDA Approval for Transdermal Antidepressant

Inhalation Products Expert Groups: Helping to Fill the Gaps

Transdermal drug technology specialists are meeting demands for methods that can painlessly deliver larger molecules in therapeutic quantities.

Breaking the Barrier: Advances in Transdermal Technology

Timothy F. Crowder, PhD, is chief technology officer at Oriel Therapeutics, Inc.

A new active dry powder inhaler has been developed using vibration frequencies to aerosolize powders.

Vibration Technology for Active Dry-Powder Inhalers

New research has led to significant advances in formulations and inhalation systems for pulmonary delivery.

Emerging Research Opportunities in Oral Inhalation Technology

Timothy A. Peterson, MChE, is an advanced product development specialist at 3M Drug Delivery Systems.

Transdermal drug delivery, a vital technology of increasing interest, offers such benefits as controlled delivery for as long as a week and improved patient convenience and compliance.

Transdermal Drug Formulation and Process Development

Ramesh Panchagnula, PhD, is a professor in the department of pharmaceutics, National Institute of Pharmaceutical Education and Research, Sector-67, Ph-X, SAS Nagar-160 062, Punjab, India, tel. -91 172 214 682 or 214 687, fax -91 172 214 692.

Recent advances in polymer science have resulted in a wide range of commercially available polymers for use in transdermal drug delivery systems.

Polymers in Transdermal Drug Delivery Systems

R. Harris Cummings is the executive director of inhalation at Magellan Laboratories, Inc., PO Box 13341, Research Triangle Park, NC 27709.

A knowledgeable and experienced contract service provider can help in the development and success of an inhalation drug product.

The Pharmaceutical Development of Inhalation Medicines and the Value of Outsourcing

Melinda S. Hopp is the director of marketing at Adhesives Research, Inc., 400 Seaks Run Rd., PO Box 100, Glen Rock, PA 17327, tel. 717.227.3456, fax 717.227.3484.

Adhesives manufacturers can be involved in the development of transdermal drug delivery products by working with pharmaceutical companies on R&D, materials qualification, manufacturing, and other product development tasks.

Developing Custom Adhesive Systems for Transdermal Drug Delivery

Adam S. Cantor, PhD, is a research specialist at 3M Drug Delivery Systems Division, 3M Center, Building 260-4N-12, St. Paul, MN 55144-1000, tel. 651.737.7524, fax 651.736.4704.

David J. Wirtanen is a senior product development engineer at 3M Drug Delivery Systems Division, 3M Center, Building 260-4N-12, St. Paul, MN 55144â1000, tel. 651. 737.7524, fax 651.736.4704, ascantor@mmm. com.

The authors discuss the solubility and adhesive performances of adhesives that incorporate monomers such as hydroxyethyl acrylate or pyrrolidonoethyl acrylate.

Specialty Dosage Drugs